Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

GSK

Gsk (GSK)

Gsk Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:GSK
DateTimeSourceHeadlineSymbolCompany
07/03/20244:22AMAlliance NewsAlliance NewsTOP NEWS: GSK inks licensing deal with CureVac for flu and Covid drugsLSE:GSKGsk Plc
07/03/20244:22AMAlliance NewsAlliance NewsTOP NEWS: GSK inks licensing deal with CureVac for flu and Covid drugsLSE:GSKGsk Plc
07/03/20242:00AMRNS Regulatory NewsGSK PLC GSK and CureVac collaboration restructuredLSE:GSKGsk Plc
07/01/202410:00AMRNS Regulatory NewsGSK PLC Total Voting RightsLSE:GSKGsk Plc
06/28/20242:43PMAlliance NewsAlliance NewsIN BRIEF: GSK reaches settlement over Zantac case in IllinoisLSE:GSKGsk Plc
06/28/20242:43PMAlliance NewsAlliance NewsIN BRIEF: GSK reaches settlement over Zantac case in IllinoisLSE:GSKGsk Plc
06/28/202412:37PMRNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
06/24/20243:55AMAlliance NewsAlliance NewsTOP NEWS: GSK hails Omjjara approval in Japan; Jemperli review in EULSE:GSKGsk Plc
06/24/20243:55AMAlliance NewsAlliance NewsTOP NEWS: GSK hails Omjjara approval in Japan; Jemperli review in EULSE:GSKGsk Plc
06/24/20242:05AMRNS Regulatory NewsGSK PLC Omjjara approved in Japan for myelofibrosisLSE:GSKGsk Plc
06/24/20242:00AMRNS Regulatory NewsGSK PLC EMA validates Jemperli marketing authorisationLSE:GSKGsk Plc
06/21/202410:30AMRNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
06/12/202410:30AMRNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
06/11/20244:32AMAlliance NewsAlliance NewsTOP NEWS: GSK takes first steps to appeal Zantac ruling in DelawareLSE:GSKGsk Plc
06/11/20244:32AMAlliance NewsAlliance NewsTOP NEWS: GSK takes first steps to appeal Zantac ruling in DelawareLSE:GSKGsk Plc
06/11/20242:00AMRNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
06/10/20242:00PMAlliance NewsAlliance NewsTOP NEWS: GSK welcomes dismissal of Zantac case in IllinoisLSE:GSKGsk Plc
06/10/20242:00PMAlliance NewsAlliance NewsTOP NEWS: GSK welcomes dismissal of Zantac case in IllinoisLSE:GSKGsk Plc
06/10/20241:27PMRNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
06/10/20243:39AMAlliance NewsAlliance NewsGSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSVLSE:GSKGsk Plc
06/10/20243:39AMAlliance NewsAlliance NewsGSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSVLSE:GSKGsk Plc
06/10/20242:00AMRNS Regulatory NewsGSK PLC FDA approves Arexvy for adults 50-59 at riskLSE:GSKGsk Plc
06/03/202410:00AMRNS Regulatory NewsGSK PLC Total Voting RightsLSE:GSKGsk Plc
06/03/20249:01AMAlliance NewsAlliance NewsGSK immunotherapy bowel cancer drug works for 100% of patientsLSE:GSKGsk Plc
06/03/20249:01AMAlliance NewsAlliance NewsGSK immunotherapy bowel cancer drug works for 100% of patientsLSE:GSKGsk Plc
06/03/20248:03AMRNS Regulatory NewsGSK PLC Unprecedented results in Jemperli trial continueLSE:GSKGsk Plc
06/03/20244:08AMAlliance NewsAlliance NewsTOP NEWS: GSK vows to appeal adverse Delaware court ruling on ZantacLSE:GSKGsk Plc
06/03/20244:08AMAlliance NewsAlliance NewsTOP NEWS: GSK vows to appeal adverse Delaware court ruling on ZantacLSE:GSKGsk Plc
06/03/20242:05AMRNS Regulatory NewsGSK PLC ASCO positive Blenrep DREAMM-8 trial resultsLSE:GSKGsk Plc
06/03/20242:00AMRNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
 Showing the most relevant articles for your search:LSE:GSK

Your Recent History

Delayed Upgrade Clock